HIF1A and neoplasm: Here we show that minor differences in the molecular nature of KRAS mutations stimulate distinct intracellular signalling pathways in normoxic conditions with different impact in basal levels of HIF-1α VEGF-A production and generation of a distinct vascular network in tumours.